ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Non-major products combined by Year
Non-major products combined ('Other products' in MD&A) — Worldwide revenue ($M) [Q1–Q3 10-Q & FY 10-K] ($M)
Eli Lilly Non-major products combined: $22,949M in FY2025, up 575.6% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
“|| Other products | 12,882 | 10,066 | 22,949 | 23,270 | (1)”
Source: Form 10-K FY2025 (filed 2026-02-12) ↗
Reported in Form 10-Q / 10-K MD&A Selected Products Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-major products combined ('Other products' in MD&A) — Worldwide revenue ($M) [Q1–Q3 10-Q & FY 10-K] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22,949 | +575.6% | Form 10-K FY2025 (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 3,397 | +43.7% | Form 10-K FY2024 (filed 2025-02-19) ↗ |
| FY2023 | Dec 31, 2023 | 2,365 | +42.2% | Form 10-K FY2023 (filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | 1,663 | +25.2% | Form 10-K FY2022 (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 1,328 | -19.5% | Form 10-K FY2021 (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 1,649 | -29.8% | Form 10-K FY2020 (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 2,348 | +38.6% | Form 10-K FY2019 (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 1,694 | -13.8% | Form 10-K FY2018 (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 1,965 | +13.8% | Form 10-K FY2017 (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 1,727 | – | Form 10-K FY2017 (filed 2018-02-20) ↗ |
Breakdown
What makes up non-major products combined
Cite this data
StockData. (2026). Eli Lilly Non-major products combined ($M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-other-products-ww
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.